300267 尔康制药
已收盘 01-13 15:00:00
资讯
新帖
简况
异动快报：尔康制药（300267）1月13日10点30分触及涨停板
证券之星 · 10:30
异动快报：尔康制药（300267）1月13日10点30分触及涨停板
尔康制药（300267）披露2025年第二次临时股东会决议公告，12月16日股价下跌2.58%
证券之星 · 2025-12-16
尔康制药（300267）披露2025年第二次临时股东会决议公告，12月16日股价下跌2.58%
尔康制药（300267）披露完成工商变更登记公告，12月09日股价下跌4.45%
证券之星 · 2025-12-09
尔康制药（300267）披露完成工商变更登记公告，12月09日股价下跌4.45%
尔康制药：有缓解流感症状药品
证券之星 · 2025-12-05
尔康制药：有缓解流感症状药品
尔康制药：尼日利亚孙公司锂矿已投产
证券之星 · 2025-12-05
尔康制药：尼日利亚孙公司锂矿已投产
尔康制药（300267）披露召开2025年第二次临时股东会通知，11月27日股价下跌1.73%
证券之星 · 2025-11-27
尔康制药（300267）披露召开2025年第二次临时股东会通知，11月27日股价下跌1.73%
尔康制药（300267）披露选举第六届董事会成员，11月17日股价下跌0.51%
证券之星 · 2025-11-17
尔康制药（300267）披露选举第六届董事会成员，11月17日股价下跌0.51%
尔康制药（300267）披露选举第六届董事会职工代表董事，11月12日股价上涨0.78%
证券之星 · 2025-11-12
尔康制药（300267）披露选举第六届董事会职工代表董事，11月12日股价上涨0.78%
尔康制药：暂无直接针对减肥领域的专项产品及业务布局
证券之星 · 2025-11-05
尔康制药：暂无直接针对减肥领域的专项产品及业务布局
尔康制药（300267）2025年三季报简析：营收净利润同比双双增长
证券之星 · 2025-10-31
尔康制药（300267）2025年三季报简析：营收净利润同比双双增长
尔康制药控股股东计划在10月29日至2026年1月28日期间减持最多2%股份
美股速递 · 2025-09-29
尔康制药控股股东计划在10月29日至2026年1月28日期间减持最多2%股份
尔康制药最新公告：控股股东帅放文拟减持不超4200万股股份
证券之星 · 2025-09-29
尔康制药最新公告：控股股东帅放文拟减持不超4200万股股份
股市必读：尔康制药中报 - 第二季度单季净利润同比增长180.17%
证券之星 · 2025-08-29
股市必读：尔康制药中报 - 第二季度单季净利润同比增长180.17%
图解尔康制药中报：第二季度单季净利润同比增长180.17%
证券之星 · 2025-08-28
图解尔康制药中报：第二季度单季净利润同比增长180.17%
尔康制药：上半年归母净利润同比增长497.36%
新京报 · 2025-08-27
尔康制药：上半年归母净利润同比增长497.36%
维生素概念盘中拉升，尔康制药涨8.69%
市场透视 · 2025-07-30
维生素概念盘中拉升，尔康制药涨8.69%
超级真菌概念盘中拉升，尔康制药涨10.09%
市场透视 · 2025-07-30
超级真菌概念盘中拉升，尔康制药涨10.09%
尔康制药(300267.SZ)：二羟丙茶碱注射液获得药品注册证书
格隆汇 · 2025-07-28
尔康制药(300267.SZ)：二羟丙茶碱注射液获得药品注册证书
流感概念盘中拉升，尔康制药等3只股票涨停
市场透视 · 2025-07-28
流感概念盘中拉升，尔康制药等3只股票涨停
异动快报：尔康制药（300267）7月28日9点37分触及涨停板
证券之星 · 2025-07-28
异动快报：尔康制药（300267）7月28日9点37分触及涨停板
加载更多
公司概况
公司名称：
湖南尔康制药股份有限公司
所属行业：
医药制造业
上市日期：
2011-09-27
主营业务：
湖南尔康制药股份有限公司的主营业务是辅料、原料药、成品药、新能源材料的生产和销售。公司的主要产品是药用辅料、成品药、原料药。
发行价格：
17.97
{"stockData":{"symbol":"300267","market":"SZ","secType":"STK","nameCN":"尔康制药","latestPrice":4.45,"timestamp":1768287831000,"preClose":3.71,"halted":0,"volume":383504323,"delay":0,"changeRate":0.1995,"floatShares":1422000000,"shares":2063000000,"eps":-0.1495,"marketStatus":"已收盘","change":0.74,"latestTime":"01-13 15:00:00","open":3.81,"high":4.45,"low":3.81,"amount":1644000000,"amplitude":0.1725,"askPrice":0,"askSize":0,"bidPrice":4.45,"bidSize":19088,"shortable":0,"etf":0,"ttmEps":-0.1495,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768354200000},"marketStatusCode":5,"adr":0,"adjPreClose":3.71,"symbolType":"stock","openAndCloseTimeList":[[1768267800000,1768275000000],[1768280400000,1768287600000]],"highLimit":4.08,"lowLimit":3.34,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":2062604870,"isCdr":false,"pbRate":1.71,"roa":"--","roe":"0.89%","epsLYR":-0.181,"committee":0,"marketValue":9179000000,"turnoverRate":0.2696,"status":0,"floatMarketCap":6330000000},"requestUrl":"/m/hq/s/300267","defaultTab":"news","newsList":[{"id":"2603098575","title":"异动快报：尔康制药（300267）1月13日10点30分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2603098575","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603098575?lang=zh_cn&edition=full","pubTime":"2026-01-13 10:30","pubTimestamp":1768271441,"startTime":"0","endTime":"0","summary":"证券之星1月13日盘中消息，10点30分尔康制药触及涨停板。其所属行业化学制药目前上涨。领涨股为尔康制药。该股为AI医疗，合成生物，医药概念热股，当日AI医疗概念上涨4.79%，合成生物概念上涨2.94%，医药概念上涨1.95%。1月12日的资金流向数据方面，主力资金净流出229.34万元，占总成交额1.24%，游资资金净流出44.79万元，占总成交额0.24%，散户资金净流入274.14万元，占总成交额1.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300012017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","300267","BK0028"],"gpt_icon":0},{"id":"2591980623","title":"尔康制药（300267）披露2025年第二次临时股东会决议公告，12月16日股价下跌2.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591980623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591980623?lang=zh_cn&edition=full","pubTime":"2025-12-16 22:11","pubTimestamp":1765894315,"startTime":"0","endTime":"0","summary":"截至2025年12月16日收盘，尔康制药报收于3.4元，较前一交易日下跌2.58%，最新总市值为70.13亿元。该股当日开盘3.49元，最高3.49元，最低3.4元，成交额达9137.42万元，换手率为1.87%。尔康制药近日发布公告称，公司于2025年12月16日召开2025年第二次临时股东会，出席会议的股东及代理人共计313名，代表股份1,011,948,647股，占公司有表决权股份总数的49.0617%。各项议案均获通过，表决程序符合相关法律法规及公司章程规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600040583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0077","300267"],"gpt_icon":0},{"id":"2590344407","title":"尔康制药（300267）披露完成工商变更登记公告，12月09日股价下跌4.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590344407","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590344407?lang=zh_cn&edition=full","pubTime":"2025-12-09 22:11","pubTimestamp":1765289495,"startTime":"0","endTime":"0","summary":"截至2025年12月9日收盘，尔康制药报收于3.65元，较前一交易日下跌4.45%，最新总市值为75.29亿元。该股当日开盘3.8元，最高3.81元，最低3.65元，成交额达2.19亿元，换手率为4.17%。尔康制药近日发布公告称，公司已于近期完成工商变更登记手续，并取得长沙市市场监督管理局换发的《营业执照》。此次变更涉及公司经营范围及注册资本等内容。上述变更事项已于2025年11月14日经公司2025年第一次临时股东大会审议通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900040320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0077","300267","BK0239"],"gpt_icon":0},{"id":"2589789242","title":"尔康制药：有缓解流感症状药品","url":"https://stock-news.laohu8.com/highlight/detail?id=2589789242","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589789242?lang=zh_cn&edition=full","pubTime":"2025-12-05 20:49","pubTimestamp":1764938973,"startTime":"0","endTime":"0","summary":"证券之星消息，尔康制药(300267)12月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司生产的药品可以抗病毒和治疗流感吗？公司的锂矿和药品各占比多少？谢谢。尔康制药回复：尊敬的投资者，您好！目前公司有可以缓解流感相关疾病症状的药品，如：复方甘草片为止咳类药品；对乙酰氨基酚片为解热镇痛类药品；氨咖黄敏胶囊为抗感冒类药品。根据公司2025年半年度报告，公司新能源行业营业收入与医药行业营业收入的比重约为1:4。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500036879.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300267","BK0028","BK0077"],"gpt_icon":0},{"id":"2589922298","title":"尔康制药：尼日利亚孙公司锂矿已投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2589922298","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589922298?lang=zh_cn&edition=full","pubTime":"2025-12-05 20:49","pubTimestamp":1764938972,"startTime":"0","endTime":"0","summary":"证券之星消息，尔康制药(300267)12月05日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘好，请问利亚锂矿什么时候可投产？矿的品位怎么样？谢谢！尔康制药回复：尊敬的投资者，您好！公司在尼日利亚的孙公司尔康矿业主要从事锂矿勘探、开采和加工业务，于2024年第四季度建成投产以来，以锂精矿产品生产为主，生产效率、产量持续提升。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500036878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300267","BK0239","BK0028"],"gpt_icon":0},{"id":"2586827225","title":"尔康制药（300267）披露召开2025年第二次临时股东会通知，11月27日股价下跌1.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586827225","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586827225?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:11","pubTimestamp":1764252680,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘，尔康制药报收于3.97元，较前一交易日下跌1.73%，最新总市值为81.89亿元。该股当日开盘4.06元，最高4.11元，最低3.91元，成交额达2.97亿元，换手率为5.27%。近日，尔康制药发布公告称，公司将于2025年12月16日召开2025年第二次临时股东会，会议由董事会召集，采用现场与网络投票相结合的方式进行。中小股东的表决情况将单独计票，网络投票将通过深交所系统进行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300267","BK0077","BK0028","BK0239"],"gpt_icon":0},{"id":"2584764697","title":"尔康制药（300267）披露选举第六届董事会成员，11月17日股价下跌0.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584764697","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584764697?lang=zh_cn&edition=full","pubTime":"2025-11-17 17:31","pubTimestamp":1763371869,"startTime":"0","endTime":"0","summary":"截至2025年11月17日收盘，尔康制药报收于3.89元，较前一交易日下跌0.51%，最新总市值为80.24亿元。近日，尔康制药发布2025年第一次临时股东大会决议公告。出席会议股东及授权代表共261名，代表股份占公司总股份的48.7916%。本次会议召集、召开及表决程序符合法律法规及《公司章程》规定，决议合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700023405.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0028","300267"],"gpt_icon":0},{"id":"2582705683","title":"尔康制药（300267）披露选举第六届董事会职工代表董事，11月12日股价上涨0.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582705683","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582705683?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:43","pubTimestamp":1762958597,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，尔康制药报收于3.88元，较前一交易日上涨0.78%，最新总市值为80.03亿元。公司近日发布公告称，湖南尔康制药股份有限公司于2025年11月12日召开职工代表大会，选举赵寻女士为第六届董事会职工代表董事。赵寻女士现任公司董事、财务总监，符合相关法律法规规定的任职资格和条件。公司第六届董事会中由职工代表担任的董事及兼任高级管理人员的董事人数未超过董事总数的二分之一，符合相关规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200041623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300267","BK0077","BK0028"],"gpt_icon":0},{"id":"2581972756","title":"尔康制药：暂无直接针对减肥领域的专项产品及业务布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2581972756","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581972756?lang=zh_cn&edition=full","pubTime":"2025-11-05 20:51","pubTimestamp":1762347070,"startTime":"0","endTime":"0","summary":"证券之星消息，尔康制药(300267)11月04日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司在减肥领域有涉足吗？尔康制药回复：尊敬的投资者，您好！目前，公司生产的成品药主要为抗菌、止血、止咳、平喘类注射剂及治疗肾病、胃病、补益安神类中成药等，暂无直接针对减肥领域的专项产品及业务布局。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500038607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300267","BK0028","BK0239","BK0077"],"gpt_icon":0},{"id":"2579011051","title":"尔康制药（300267）2025年三季报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2579011051","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579011051?lang=zh_cn&edition=full","pubTime":"2025-10-31 06:48","pubTimestamp":1761864539,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期尔康制药发布2025年三季报。根据财报显示，尔康制药营收净利润同比双双增长。截至本报告期末，公司营业总收入10.06亿元，同比上升17.81%，归母净利润3957.59万元，同比上升255.4%。按单季度数据看，第三季度营业总收入3.25亿元，同比上升39.32%，第三季度归母净利润194.12万元，同比上升106.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100009903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300267"],"gpt_icon":0},{"id":"1122082007","title":"尔康制药控股股东计划在10月29日至2026年1月28日期间减持最多2%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1122082007","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122082007?lang=zh_cn&edition=full","pubTime":"2025-09-29 19:30","pubTimestamp":1759145405,"startTime":"0","endTime":"0","summary":"尔康制药发布公告称，公司控股股东计划在2024年10月29日至2026年1月28日期间减持公司股份，减持比例不超过公司总股本的2%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0077","BK0239","300267","BK0028"],"gpt_icon":0},{"id":"2571870703","title":"尔康制药最新公告：控股股东帅放文拟减持不超4200万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2571870703","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571870703?lang=zh_cn&edition=full","pubTime":"2025-09-29 19:20","pubTimestamp":1759144851,"startTime":"0","endTime":"0","summary":"尔康制药(300267.SZ)公告称，公司控股股东帅放文计划在本公告发布之日起15个交易日后的3个月内，以集中竞价或大宗交易方式合计减持公司股份不超过4200万股，即不超过公司总股本的2.04%。减持原因为股东自身资金需求，减持价格不低于首次公开发行股票时的发行价。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900029284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300267","BK0077","BK0028","BK0239"],"gpt_icon":0},{"id":"2563063242","title":"股市必读：尔康制药中报 - 第二季度单季净利润同比增长180.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563063242","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563063242?lang=zh_cn&edition=full","pubTime":"2025-08-29 03:08","pubTimestamp":1756408091,"startTime":"0","endTime":"0","summary":"来自业绩披露要点：尔康制药2025年中报归母净利润同比增长497.36%，扣非净利润同比增长1357.97%。股本股东变化股东户数变动近日尔康制药披露，截至2025年6月30日公司股东户数为4.27万户，较3月31日增加1802.0户，增幅为4.4%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082900001461.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300267"],"gpt_icon":0},{"id":"2562624724","title":"图解尔康制药中报：第二季度单季净利润同比增长180.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562624724","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562624724?lang=zh_cn&edition=full","pubTime":"2025-08-28 02:51","pubTimestamp":1756320718,"startTime":"0","endTime":"0","summary":"证券之星消息，尔康制药2025年中报显示，公司主营收入6.82亿元，同比上升9.74%；归母净利润3763.46万元，同比上升497.36%；扣非净利润3301.87万元，同比上升1357.97%；其中2025年第二季度，公司单季度主营收入3.28亿元，同比下降4.98%；单季度归母净利润952.21万元，同比上升180.17%；单季度扣非净利润830.94万元，同比上升48.19%；负债率12.56%，投资收益289.67万元，财务费用142.78万元，毛利率27.49%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800002139.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300267"],"gpt_icon":0},{"id":"2562674066","title":"尔康制药：上半年归母净利润同比增长497.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562674066","media":"新京报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562674066?lang=zh_cn&edition=full","pubTime":"2025-08-27 22:13","pubTimestamp":1756303980,"startTime":"0","endTime":"0","summary":"转自：贝壳财经新京报贝壳财经讯 8月27日晚间，尔康制药公告，2025年上半年营业收入6.82亿元，同比增长9.74%，归母净利润3763.46万元，同比增长497.36%。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-08-27/doc-infnmvkz8935611.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-08-27/doc-infnmvkz8935611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300267"],"gpt_icon":0},{"id":"2555109936","title":"维生素概念盘中拉升，尔康制药涨8.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555109936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555109936?lang=zh_cn&edition=full","pubTime":"2025-07-30 11:15","pubTimestamp":1753845325,"startTime":"0","endTime":"0","summary":"07月30日，维生素概念盘中拉升，截至11点15分，维生素概念整体指数上涨1.02%，报1783.160点。从个股上来看，该概念的成分股中，尔康制药涨8.69%，梅花生物、浙江医药、新 和 成涨幅居前。从资金上来看，截止发稿，维生素概念主力净流入为-1.59亿，其中华润三九受到资金热捧，主力净流入5509.24万；拉长时间线来看，该板块近20日主力资金净流入-18.33亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073011152594c2e836&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073011152594c2e836&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0239","600873","BK0077","BK0028","300267","BK0191","600216"],"gpt_icon":0},{"id":"2555333096","title":"超级真菌概念盘中拉升，尔康制药涨10.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555333096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555333096?lang=zh_cn&edition=full","pubTime":"2025-07-30 10:22","pubTimestamp":1753842140,"startTime":"0","endTime":"0","summary":"07月30日，超级真菌概念盘中拉升，截至10点22分，超级真菌概念整体指数上涨1.00%，报891.820点。从个股上来看，该概念的成分股中，尔康制药涨10.09%，科伦药业、国药现代、白云山涨幅居前。从资金上来看，截止发稿，超级真菌概念主力净流入为-4456.62万，其中华海药业受到资金热捧，主力净流入2823.37万；拉长时间线来看，该板块近20日主力资金净流入-11.26亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730102220a6c8c4f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730102220a6c8c4f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0082","BK0020","300267","BK0028","BK0132","BK0010","600420","600521","BK0239","BK0077"],"gpt_icon":0},{"id":"2554271247","title":"尔康制药(300267.SZ)：二羟丙茶碱注射液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2554271247","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554271247?lang=zh_cn&edition=full","pubTime":"2025-07-28 17:39","pubTimestamp":1753695564,"startTime":"0","endTime":"0","summary":"格隆汇7月28日丨尔康制药(300267.SZ)公布，公司于近日收到国家药品监督管理局签发的《药品注册证书》，公司二羟丙茶碱注射液获批注册。二羟丙茶碱属于平滑肌松弛药，有扩张支气管和冠状动脉的作用，并有利尿作用，在胃液中稳定，平喘作用与氨茶碱相似，尤适用于伴有心动过速的患者。适用于支气管哮喘、喘息型支气管炎、阻塞性肺气肿等以缓解喘息症状，也用于心源性肺水肿引起的哮喘。二羟丙茶碱注射液属于《国家基本医疗保险、工伤保险和生育保险药品目录(2024年)》乙类品种。公司该药品是按新的化学药品注册分类获批上市，获批后视同通过一致性评价。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/28173952025045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0028","BK0239","300267","BK0077"],"gpt_icon":0},{"id":"2554742515","title":"流感概念盘中拉升，尔康制药等3只股票涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2554742515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554742515?lang=zh_cn&edition=full","pubTime":"2025-07-28 09:45","pubTimestamp":1753667150,"startTime":"0","endTime":"0","summary":"07月28日，流感概念盘中拉升，截至09点45分，流感概念整体指数上涨1.12%，报1097.860点。从个股上来看，该概念的成分股中，科华生物涨幅超过10%，尔康制药等3只股票涨停，丰原药业、联环药业等6只股涨幅超过5%。从资金上来看，截止发稿，流感概念主力净流入为3.69亿，其中尔康制药受到资金热捧，主力净流入1.39亿；拉长时间线来看，该板块近20日主力资金净流入-76.26亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728094550a6c4e20a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728094550a6c4e20a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300267","BK0028","BK0077","BK0239","600513"],"gpt_icon":0},{"id":"2554744801","title":"异动快报：尔康制药（300267）7月28日9点37分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2554744801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554744801?lang=zh_cn&edition=full","pubTime":"2025-07-28 09:40","pubTimestamp":1753666855,"startTime":"0","endTime":"0","summary":"证券之星7月28日盘中消息，9点37分尔康制药触及涨停板。目前价格4.51，上涨19.95%。其所属行业化学制药目前上涨。领涨股为尔康制药。该股为化学原料药，中药，医药概念热股，当日化学原料药概念上涨1.04%，中药概念上涨0.91%，医药概念上涨0.9%。7月25日的资金流向数据方面，主力资金净流入2674.37万元，占总成交额2.81%，游资资金净流入2214.27万元，占总成交额2.32%，散户资金净流出4888.63万元，占总成交额5.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072800004285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300267","BK0028","BK0239","BK0077"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768288488664,"stockEarnings":[{"period":"1week","weight":0.0421},{"period":"1month","weight":0.057},{"period":"3month","weight":0.1042},{"period":"6month","weight":0.0661},{"period":"1year","weight":0.4606},{"period":"ytd","weight":0.088}],"compareEarnings":[{"period":"1week","weight":0.0353},{"period":"1month","weight":0.0709},{"period":"3month","weight":0.0776},{"period":"6month","weight":0.1888},{"period":"1year","weight":0.3146},{"period":"ytd","weight":0.0495}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖南尔康制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"49105人(较上一季度增加14.88%)","perCapita":"28966股","listingDate":"2011-09-27","address":"湖南省长沙市浏阳市经济开发区康平路167号","registeredCapital":"206260万元","survey":" 湖南尔康制药股份有限公司的主营业务是辅料、原料药、成品药、新能源材料的生产和销售。公司的主要产品是药用辅料、成品药、原料药。","listedPrice":17.97},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"尔康制药(300267)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供尔康制药(300267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"尔康制药,300267,尔康制药股票,尔康制药股票老虎,尔康制药股票老虎国际,尔康制药行情,尔康制药股票行情,尔康制药股价,尔康制药股市,尔康制药股票价格,尔康制药股票交易,尔康制药股票购买,尔康制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"尔康制药(300267)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供尔康制药(300267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}